We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Chad Therapeutics, | AMEX:CTU | AMEX | Ordinary Share |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.00 | - |
RNS Number:3138J Conister Trust PLC 27 March 2003 Conister Trust PLC Re Directorate Change The board of Conister Trust is pleased to announce the appointment of Gareth Alan Jones, BSc, ACIB, MBA as an Executive Director with effect from 31 March 2003. Mr Jones, aged 34, has had a career which has spanned 13 years in retail and corporate banking, both in the UK and overseas. As well as traditional banking experience with National Westminster Bank, he has held roles in investor relations and e-commerce, and has specialised in project management. Former positions include a senior consultancy role with iXL and with Standard Chartered Bank. He is an Associate of the Institute of Financial Services, a graduate in chemistry and holds an MBA from London Business School. He is Manx resident. There are no other matters which are required to be announced as required under paragraph (f) of Schedule 2 of the AIM Rules. 27 March 2003 This information is provided by RNS The company news service from the London Stock Exchange END BOABRGDXXBDGGXR
1 Year Chad Therapeutics Chart |
1 Month Chad Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions